Warren Barker Wien Center for Alzheimer’s Disease & Memory Disorders Mount Sinai Medical Center Phone: 305-674-2592 Fax: 305-674-2996 8 TH ANNUAL MCI SYMPOSIUM For information please visit: www.mcisymposium.org or Email: [email protected]March 12 - 13 2010 Save the Date! Accreditation Mount Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. Mount Sinai designates this educational activity for a maximum of 11 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. Psychology Credit The Symposium on Early Alzheimer’s Disease has been approved by the Florida Board of Psychology and the Miami Area Geriatric Education Center (MAGEC). This program has been approved for 11 contact hours. (MAGEC CE Broker Tracking #20-252935). Disclosure Statement Faculty relationship(s) with industry will be disclosed and available in the Symposium Syllabus and at the meeting site. In addition, disclosure to the audience will be made by the Faculty prior to their presentations. Mount Sinai Medical Center in accordance with the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education (ACCME) will disclose the existence of any significant financial interest or other relationship that a faculty member/spouse or partner has (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services and (2) with any commercial supporters of the activity. Faculty is also required to disclose to the audience, during their presentation, any investigational/unlabeled use that is discussed.The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making a presentation, but rather to provide the attendees with information on which they can make their own judgments. Symposium Information Please contact one of the following: Wien Center 4300 Alton Road Miami Beach, FL 33140 Presented By: Mount Sinai Medical Center, Miami Beach, Florida FRIDAY – SATURDAY March 12 - 13, 2010 Symposium Location: Eden Roc Hotel 4525 Collins Avenue Miami Beach, FL 33140 Program Director: Ranjan Duara, MD Medical Director, Wien Center for Alzheimer’s Disease and Memory Disorders Mount Sinai Medical Center, Miami Beach, FL 8 TH ANNUAL MARK YOUR CALENDAR Symposium on Early Alzheimer’s Disease M ILD C OGNITIVE I MPAIRMENT (MCI) S YMPOSIUM Theme for 2010: Focus on Early and Preclinical Alzheimers Disease www.mcisymposium.org Yirah Ochoa Wien Center for Alzheimer’s Disease & Memory Disorders Mount Sinai Medical Center Phone: 305-674-2259 Email: [email protected]E-mail: [email protected]Web: www.mcisymposium.org
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Warren BarkerWien Center for Alzheimer’s Disease& Memory DisordersMount Sinai Medical CenterPhone: 305-674-2592 Fax: 305-674-2996
AccreditationMount Sinai Medical Center isaccredited by the AccreditationCouncil for Continuing MedicalEducation (ACCME) to sponsorcontinuing medical education forphysicians. Mount Sinai designatesthis educational activity for amaximum of 11 AMA PRACategory 1 Credits. Physiciansshould only claim creditcommensurate with the extent oftheir participation in the activity.
Psychology CreditThe Symposium on EarlyAlzheimer’s Disease has beenapproved by the Florida Board ofPsychology and the Miami AreaGeriatric Education Center(MAGEC). This program has beenapproved for 11 contact hours.(MAGEC CE Broker Tracking#20-252935).
Disclosure StatementFaculty relationship(s) with industry will be disclosed and available in the SymposiumSyllabus and at the meeting site. In addition, disclosure to the audience will be madeby the Faculty prior to their presentations.
Mount Sinai Medical Center in accordance with the Standards for CommercialSupport of the Accreditation Council for Continuing Medical Education (ACCME) willdisclose the existence of any significant financial interest or other relationship that afaculty member/spouse or partner has (1) with the manufacturer(s) of anycommercial product(s) and/or provider(s) of commercial services and (2) with anycommercial supporters of the activity. Faculty is also required to disclose to theaudience, during their presentation, any investigational/unlabeled use that isdiscussed.The intent of this disclosure is not to prevent a speaker with a significantfinancial or other relationship from making a presentation, but rather to provide theattendees with information on which they can make their own judgments.
Symposium InformationPlease contact one of the following:
Wien Center4300 Alton Road
Miami Beach, FL 33140
Presented By:Mount Sinai Medical Center, Miami Beach, Florida
FRIDAY – SATURDAY March 12 - 13, 2010
Symposium Location:Eden Roc Hotel4525 Collins AvenueMiami Beach, FL 33140
Program Director:Ranjan Duara, MDMedical Director, Wien Center for Alzheimer’s Disease and Memory DisordersMount Sinai Medical Center, Miami Beach, FL
8THANNUAL
MARK YOUR CALENDAR
Symposium onEarly Alzheimer’s
Disease
MILD COGNITIVE IMPAIRMENT (MCI) SYMPOSIUMTheme for 2010: Focus on Early and Preclinical Alzheimers Disease
www.mcisymposium.org
Yirah OchoaWien Center for Alzheimer’s Disease& Memory DisordersMount Sinai Medical CenterPhone: 305-674-2259Email: [email protected]
Distinguished FacultyProgram DirectorRanjan Duara, MDMedical Director, Wien Center for Alzheimer’s Disease and Memory DisordersMount Sinai Medical Center, Miami BeachDepartments of Medicine, Neurology and PsychiatryMiller School of Medicine, University of Miami, Miami, FLDepartment of Neurology, University of South Florida College of Medicine, Tampa, FL
Needs Assessment
Unless ways are found to preventAlzheimer’s Disease (AD) or delay its onset,it is projected that 13 million people in theUnited States will have AD by 2050.Individuals with AD suffer from cognitive andfunctional impairment, loss of productivityand significant deterioration in over-allquality of life. Most will develop problematicbehaviors and many will need long-termcare. In addition, caregivers of the patientsare often affected by physical burden,emotional distress and financial hardship.
Since the development of criteria for ADalmost twenty-five years ago, there havebeen major advances in our understandingof the biology and early clinical features ofAD and other causes of dementia. This hasled to improvements in clinical assessmentand brain imaging, which has enabledclinicians to diagnose AD more reliably andat an earlier stage of illness. Patientsclassified as having a pre-dementia conditionknown as Mild Cognitive Impairment (MCI)are at increased risk for progressing to ADor dementia. Thus, American Academy ofNeurology Practice Guidelines recommendthat clinicians identify and monitor MCIusing cognitive test batteries. The earlydiagnosis of dementing illnesses can lead tobeneficial pharmacological treatment andnon-pharmacological interventions(e.g., caregiver education, legal andfinancial counseling).
However, several studies have shown thatphysicians often lack knowledge of the earlysigns and symptoms of AD resulting in adelay in diagnosis and intervention. Manyphysicians are also unaware of theadvantages and limitations of newassessment tools, or how to interpret theirresults in clinical practice. Clinicians alsoneed information about the latest ADresearch to respond to patient questions andto refer to clinical trials.
Educational ObjectivesThe purpose of this symposium is to provide a forum fornew information and for in-depth discussions aboutadvances in research, related to the clinical diagnosis,progression and treatment of Alzheimer’s Disease. Thissymposium will emphasize the early stage of AD andthe preclinical deficits that are associated withincreased risk for subsequent dementia.
We will examine recent developments in understandingrisk factors which lay the groundwork for potentialstrategies for treating and delaying Alzheimer’sdisease. We will present results from severallongitudinal and cross-sectional studies that haveexplored clinical, imaging and biomarkers factors thatare related to AD.
The symposium will include two keynote addresses andfour individually themed symposia, each featuringnational experts in the fields of neurology, psychiatry,geriatrics, neuropsychology, radiology, epidemiology,genetics and pharmacology. Each mini-symposium willbe followed by an extended discussion period,allowing active audience participation to promote abetter understanding of the issues.
Upon completion of this symposium, the attendeesshould be able to:
• Describe the rationale for a preclinical AD diagnosis.
• Name preclinical factors that increase the risk forsubsequent AD or dementia.
• Discuss the results of clinical drug studies andstrategies to enrich prevention trials.
• Recognize the difference and similarities betweenamnestic and non-amnestic MCI.
• Understand the challenges in interpreting the resultsof psychometric tests in MCI and early AD.
Keynote Speakers:
Mark W. Bondi, Ph.D., ABPP/CNProfessor of PsychiatryVA San Diego Healthcare SystemUniversity of CaliforniaSan Diego, California
John Morris, MDFriedman Distinguished Professor ofNeurologyWashington University School of MedicineSt. Louis, Missouri
Distinguished Faculty:
Rhoda Au, PhDAssociate Professor of NeurologyBoston University School of MedicineBoston, Massachusetts
Richard J. Caselli, MDProfessor and Chair, Department ofNeurologyClinical Core Director, Arizona Alzheimer'sDisease CenterMayo Clinic ArizonaScottsdale, Arizona
Katherine (Nutter-Upham) Eskine, MAPhD Candidate in the Cognition Brain andBehavior ProgramCity University of New YorkBrooklyn, New York
Norman L. Foster, M.D.Professor of NeurologyDirector, Center for Alzheimer’s Care,Imaging and ResearchSenior Investigator, The Brain Institute at TheUniversity of UtahSalt Lake City, Utah
Mary Ganguli, MD, MPHProfessor of Psychiatry and EpidemiologyUniversity of Pittsburgh School of MedicinePittsburgh, Pennsylvania
Robert C. Green, MD, MPHProfessor of Neurology, Genetics, andEpidemiologyBoston University School of MedicineDirector, Boston University Alzheimer’sDisease Clinical and Research ProgramBoston, Massachusetts
Amy Jak, Ph.D.Assistant Professor of PsychiatryUniversity of California, San Diego, Schoolof MedicineDirector, TBI Cognitive Rehabilitation Clinic,VA San Diego Healthcare SystemSan Diego, California
David Loewenstein PhD, ABPP/CNProfessor of Psychiatry and BehavioralSciences and Neurology,University of Miami Miller School ofMedicineWien Center for Alzheimer’s Disease andMemory Disorders, Mount SinaiMiami, Florida
Jennifer J. Manly, PhDAssociate Professor of NeuropsychologyTaub Institute for Research on Alzheimer'sDisease and the Aging BrainColumbia University Medical CenterNew York City, New York
Lisa Mosconi, PhDAssistant Professor of PsychiatryPET Imaging Research Director, Center forBrain HealthNew York University School of MedicineNew York City, New York
Ronald Petersen, MD, PhDProfessor of Neurology and Alzheimer’sDisease ResearchMayo Medical SchoolRochester, Minnesota
Joseph Quinn, MDCo-Director, Northwest Parkinson’s DiseaseResearch, Education and Clinical CentersAssociate Professor, Department ofNeurologyOregon Health & Science UniversityPortland, Oregon
Catherine M. Roe, PhDResearch InstructorAlzheimer's Disease Research CenterWashington University School of MedicineSt. Louis, Missouri
Eric Siemers, MDMedical Director, Alzheimer's Disease TeamLilly Corporate Center, Eli Lilly and CompanyIndianapolis, Indiana
Reisa Sperling, M.D.Associate Professor of Neurology, HarvardMedical SchoolDirector of Clinical Research, MemoryDisorders UnitBrigham and Women's HospitalBoston, Massachusetts
AM
7:30 - 8:30 Breakfast Buffet
8:30 - 9:15 Keynote Address: Amnestic andNon-amnestic MCI are Distinct Entities –Fact or Fiction?
Mark Bondi, PhD
9:15 - 9:30 Break
9:30 - 11:30 Mini-Symposium: Challenges in InterpretingPsychometric Test Results in Early AD, MCIand PreMCI
Chair: Mary Ganguli, MD
PreMCI, Alzheimer’s Disease andCognitive Reserve
Catherine Roe, PhD
Verbal Fluency and Executive Function inMCI and Subjects with CognitiveComplaints
Katherine Nutter-Upham, MA
Quantification of NeuropsychologicalApproaches to Defining MCI Subtypes
Amy Jak, PhD
Assessment of Cognitive Impairment inMinority Population
Jennifer Manly, PhD
11:30 - 11:45 Break
11:45 - 12:30 Open Discussion
12:30 Adjourn
Saturday, March 13, 2010
PM
1:15 - 2:30 Lunch Break
2:30 - 4:15 Mini-Symposium: Biomarkers for Early AD,MCI and PreMCI
Chair: TBD
FDG-PET Imaging in the Evaluation of VeryEarly AD: Contributions of the Alzheimer’sDisease Neuroimaging Initiative (ADNI)
Norman Foster, MD
Amyloid Imaging and fMRI studies inEarly AD
Reisa Sperling, MD
Cerebral Glucose Metabolism in PreClinicalAD with Maternal Family History of AD
________________________________________________________________________________________________________________________________CITY STATE ZIP CODE COUNTRY
________________________________________________________________________________________________________________________________NAME & ADDRESS ON CARD IF DIFFERENT THAN ABOVE
Payment must accompany registration form. Refund Policy: Full refund will be given if written noticeis received not later than February 21,2010. All refunds will be processed after the meeting.
Eden Roc Hotel:4525 Collins Avenue, Miami Beach, Florida 33140Phone: (800) 468-3571 or (305) 531-0000Web-Site: www.marriott.com/miasr
The place to experience Miami Beach… Onmagnificently landscaped oceanfront grounds,the new Eden Roc brings dynamic design,unsurpassed luxury and cutting-edgetechnology together in one place – the place
to be on Miami Beach.Following a $200million dollarrenovation andexpansion, the boldnew Eden Roc, ARenaissance Beach
Resort and Spa, embraces it role as a timelesstreasure, yet welcomes guests with a contemporary spirit. In thisstunning locale, a pulsing nightlife, brilliant white-sand beaches, andsizzling culture combine for the perfect getaway. At the Eden RocHotel you will savor the best of this colorful city.
DRESS
Business casual attire is appropriate for all events. A light sweater or jacketis recommended in the meeting rooms.
Hotel Reservations
For the convenience of the 8th Annual Symposium on early Alzheimer’sDisease attendees, a limited number of rooms have been reserved at thespecial daily rate of $200 (single or double occupancy, plus resort fees,state and local taxes). To receive this conference rate, reservations must bemade directly with the Eden Roc Hotel and you must mention that you are aregistrant of the 8th Annual Symposium on Early Alzheimer’s Disease.Rooms will be held at the special rate until Thursday, February 18, 2010.Rooms at the discounted rate will be allocated on a first-come, first-servedbasis. Reservations received after the cut-off date are subject to availabilityand prevailing rates.
Mount Sinai Medical Center is committed to making its CME activitiesaccessible to all individuals. If you are in need of an accommodation, pleasedo not hesitate to call and/or submit a description of your needs in writingwithin 5 weeks of the activity in order to receive service.
FOR ROOM RESERVATIONS CALL: (800) 468-3571 or (305) 531-0000OR ACCESS THE HOTEL WEB SITE VIA www.marriott.com/miasr